These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16382702)

  • 1. Effect of montelukast on basophil releasability in patients with asthma.
    Sade K; Kivity S; Fireman E; Schwartz Y; Kivity S
    Isr Med Assoc J; 2005 Dec; 7(12):792-5. PubMed ID: 16382702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
    Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
    Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
    Kivity S; Onn A; Agami O; Fireman E
    Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
    Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
    Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
    J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast in general pediatric practices.
    Ngamphaiboon J
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
    Stelmach I; Majak P; Jerzynska J; Kuna P
    Clin Exp Allergy; 2005 Feb; 35(2):213-20. PubMed ID: 15725194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast.
    Simons FE; Johnston L; Gu X; Simons KJ
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):44-50. PubMed ID: 11206237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
    J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
    Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
    Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
    Yanase DJ; David-Bajar K
    J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients.
    Gürer US; Büyüköztürk S; Palandüz S; Gürbüz B; Cevikbaş A
    Int Immunopharmacol; 2003 Sep; 3(9):1257-60. PubMed ID: 12890423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
    Sanada S; Tanaka T; Kameyoshi Y; Hide M
    Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
    Amirav I
    Isr Med Assoc J; 2008 Apr; 10(4):287-91. PubMed ID: 18548983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
    Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
    Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.